TrialDiabetes, obesity & metabolism2017

Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial.

Yasuo Terauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.